Lilly moves ahead with Indianapolis project amid job cuts


Eli Lilly and Co. says it is going ahead with a $72 million project updating an insulin manufacturing facility in Indianapolis even as the drugmaker plans to cut about 3,500 jobs from its global workforce.



from Biotech News